You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

AIDS Vaccines

Showing 26 - 50 of 4,451
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

HIV Trial in Entebbe, Kampala (ALVAC-HIV MN120TMG (vCP205), ALVAC-RG Rabies Glycoprotein (vCP65))

Completed
  • HIV Infections
  • ALVAC-HIV MN120TMG (vCP205)
  • ALVAC-RG Rabies Glycoprotein (vCP65)
  • Entebbe, Uganda
  • +1 more
Oct 28, 2021

HIV Trial in Rochester (HIVAC-1e, gp160 Vaccine (MicroGeneSys))

Completed
  • HIV Infections
  • HIVAC-1e
  • gp160 Vaccine (MicroGeneSys)
  • Rochester, New York
    Univ. of Rochester AVEG
Oct 26, 2021

HIV Trial in United States (rgp120/HIV-1MN, rgp120/HIV-1 SF-2)

Completed
  • HIV Infections
  • rgp120/HIV-1MN
  • rgp120/HIV-1 SF-2
  • Birmingham, Alabama
  • +6 more
Oct 28, 2021

HIV Trial in Seattle (HIVAC-1e, gp160 Vaccine (MicroGeneSys))

Completed
  • HIV Infections
  • HIVAC-1e
  • gp160 Vaccine (MicroGeneSys)
  • Seattle, Washington
    Children's Hospital & Medical Center / Seattle ACTU
Oct 26, 2021

HIV Trial in United States (Aluminum hydroxide, MF59, rgp120/HIV-1IIIB)

Completed
  • HIV Infections
  • Aluminum hydroxide
  • +5 more
  • Los Angeles, California
  • +9 more
Oct 27, 2021

HIV Trial in Pittsburgh (rgp120/HIV-1 SF-2, Env 2-3, HIVAC-1e)

Completed
  • HIV Infections
  • rgp120/HIV-1 SF-2
  • +3 more
  • Pittsburgh, Pennsylvania
    JHU AVEG
Oct 27, 2021

HIV Trial in United States (ALVAC(2)120(B,MN)GNP (vCP1452), gp160 MN/LAI-2, ALVAC(1)120(B,MN)GNP (vCP1433))

Completed
  • HIV Infections
  • ALVAC(2)120(B,MN)GNP (vCP1452)
  • +4 more
  • Birmingham, Alabama
  • +5 more
Oct 27, 2021

HIV, HIV Seronegativity Trial in United States (HIV p24/MF59 Vaccine, ALVAC-HIV MN120TMG (vCP205), ALVAC-RG Rabies Glycoprotein

Completed
  • HIV Infections
  • HIV Seronegativity
  • HIV p24/MF59 Vaccine
  • +3 more
  • Birmingham, Alabama
  • +6 more
Oct 27, 2021

HIV, HIV Seronegativity Trial in United States (ALVAC-HIV MN120TMG (vCP205))

Completed
  • HIV Infections
  • HIV Seronegativity
  • ALVAC-HIV MN120TMG (vCP205)
  • Birmingham, Alabama
  • +5 more
Oct 28, 2021

HIV Trial in United States (FP conjugate vaccine (25 mcg), FP conjugate vaccine (200 mcg), Trimer 6931 (100 mcg))

Not yet recruiting
  • HIV
  • FP conjugate vaccine (25 mcg)
  • +5 more
  • Los Angeles, California
  • +6 more
Jul 19, 2022

Vaccine Hesitancy, Vaccine Refusal, Health Knowledge, Attitudes, Practice Trial in Paris (Activité Vaccins et Vaccination -

Completed
  • Vaccine Hesitancy
  • +2 more
  • Activité Vaccins et Vaccination - LAMAP
  • Kidivax Chatbot
  • Paris, France
    Institut Jean Nicod, Département d'études cognitives, École Norm
Nov 24, 2023

HIV Trial in United States (ALVAC(2)120(B,MN)GNP (vCP1452), MN rgp120/HIV-1 and GNE8 rgp120/HIV-1)

Completed
  • HIV Infections
  • ALVAC(2)120(B,MN)GNP (vCP1452)
  • MN rgp120/HIV-1 and GNE8 rgp120/HIV-1
  • Birmingham, Alabama
  • +16 more
Oct 13, 2021

HIV Trial in United States (BG505 MD39.3 mRNA, BG505 MD39.3 gp151 mRNA, BG505 MD39.3 gp151 CD4KO mRNA)

Suspended
  • HIV Infections
  • BG505 MD39.3 mRNA
  • +2 more
  • Birmingham, Alabama
  • +9 more
Feb 1, 2023

HIV, HIV Seronegativity Trial in Rochester, Nashville, Seattle (MTP-PE/MF59, Env 2-3)

Completed
  • HIV Infections
  • HIV Seronegativity
  • MTP-PE/MF59
  • Env 2-3
  • Rochester, New York
  • +2 more
Oct 28, 2021

HIV Trial in Rochester, Seattle (gp160 Vaccine (Immuno-AG), rgp120/HIV-1IIIB, rgp120/HIV-1MN)

Completed
  • HIV Infections
  • gp160 Vaccine (Immuno-AG)
  • +4 more
  • Rochester, New York
  • +1 more
Oct 28, 2021

HIV, Hepatitis B, Measles Trial in Puerto Rico, United States (Diphtheria & Tetanus Toxoids & Acellular Pertussis Vaccine

Completed
  • HIV Infections
  • +4 more
  • Diphtheria & Tetanus Toxoids & Acellular Pertussis Vaccine Adsorbed
  • +4 more
  • Birmingham, Alabama
  • +39 more
Oct 28, 2021

HIV, HIV Seronegativity Trial in Baltimore (Salmonella typhi CVD 908-HIV-1 LAI gp 120 (VVG 203), Aluminum hydroxide, MF59)

Completed
  • HIV Infections
  • HIV Seronegativity
  • Salmonella typhi CVD 908-HIV-1 LAI gp 120 (VVG 203)
  • +3 more
  • Baltimore, Maryland
    JHU AVEG
Oct 27, 2021

HIV Trial in United States (Aluminum hydroxide, QS-21, rgp120/HIV-1MN)

Completed
  • HIV Infections
  • Aluminum hydroxide
  • +2 more
  • Saint Louis, Missouri
  • +3 more
Oct 28, 2021

HIV Trial in Baltimore (ALVAC-HIV gp160MN (vCP125), ALVAC-RG Rabies Glycoprotein (vCP65), rgp120/HIV-1 SF-2)

Completed
  • HIV Infections
  • ALVAC-HIV gp160MN (vCP125)
  • +2 more
  • Baltimore, Maryland
    JHU AVEG
Oct 27, 2021

COVID-19 Prevention Trial in Worldwide (Ad26.COV2.S)

Recruiting
  • COVID-19 Prevention
  • Ad26.COV2.S
  • Birmingham, Alabama
  • +48 more
Aug 2, 2022

Ebola Virus Disease, Marburg Virus Disease Trial in Oklahoma City (cAd3-Marburg, cAd3-EBO-S)

Completed
  • Ebola Virus Disease
  • Marburg Virus Disease
  • cAd3-Marburg
  • cAd3-EBO-S
  • Oklahoma City, Oklahoma
    Oklahoma Blood Institute (OBI)
Aug 2, 2022

HIV Trial in Iowa City, New York (Tetanus Toxoid Vaccine, Hepatitis A Vaccine (Inactivated), HIV-1 Immunogen)

Completed
  • HIV Infections
  • Tetanus Toxoid Vaccine
  • +3 more
  • Iowa City, Iowa
  • +1 more
Oct 27, 2021

Therapeutic HIV Vaccination on Control of HIV After

Completed
  • HIV Infections
  • Therapeutic vaccinations from A5058s
  • Torrance, California
  • +13 more
Oct 28, 2021

HIV Trial in United States (VRC-HIVDNA009-00-VP (Gag-Pol-Nef-multiclade-Env) with adjuvant VRC-ADJDNA004-IL2-VP)

Completed
  • HIV Infections
  • VRC-HIVDNA009-00-VP (Gag-Pol-Nef-multiclade-Env) with adjuvant VRC-ADJDNA004-IL2-VP
  • Baltimore, Maryland
  • +6 more
Oct 13, 2021

HIV Trial in Boston (env (A,B,C,A/E)/gag (C) DNA Vaccine, gp120 (A,B,C,A/E) Protein Vaccine, GLA-SE adjuvant)

Active, not recruiting
  • HIV Infections
  • env (A,B,C,A/E)/gag (C) DNA Vaccine
  • +3 more
  • Boston, Massachusetts
    Brigham and Women's Hospital
Jun 8, 2022